WHO ICTRP trial
Phase I Study of MEDI-507 to Treat Lymphoproliferative Disease
NCT00071825 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT00071825 |
|---|---|
| Public title | Phase I Study of MEDI-507 to Treat Lymphoproliferative Disease |
| Scientific title | Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease |
| Primary sponsor | National Cancer Institute (NCI) |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | United States |
| Conditions | Lymphoproliferative Disorders |
| Interventions | Drug: MEDI-507 |
| Registration date | Oct 31, 2003 |
| Target size | 29 |
| Secondary IDs | 04-C-0031;040031 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: